ProQR Therapeutics N.V. (PRQR)
NASDAQ: PRQR · Real-Time Price · USD
1.480
-0.010 (-0.67%)
At close: Apr 28, 2026, 4:00 PM EDT
1.550
+0.070 (4.73%)
After-hours: Apr 28, 2026, 7:53 PM EDT
ProQR Therapeutics Employees
ProQR Therapeutics had 187 employees as of December 31, 2025. The number of employees increased by 21 or 12.34% compared to the previous year.
Employees
187
Change (1Y)
21
Growth (1Y)
12.34%
Revenue / Employee
$102,858
Profits / Employee
-$265,430
Market Cap
155.93M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Fate Therapeutics | 161 |
| Molecular Partners AG | 134 |
| Alps Group | 93 |
| Agenus | 81 |
| Tenaya Therapeutics | 70 |
| Spero Therapeutics | 25 |
| Black Diamond Therapeutics | 21 |
| Galectin Therapeutics | 9 |
PRQR News
- 20 days ago - ProQR Highlights Pipeline Expansion and Multiple Upcoming Clinical Catalysts at Investor and Analyst Event - GlobeNewsWire
- 20 days ago - ProQR Therapeutics Transcript: Status update - Transcripts
- 20 days ago - ProQR Announces Partnership with Ginkgo Bioworks and Formation of AI Advisory Board - GlobeNewsWire
- 4 weeks ago - ProQR to Host Virtual Investor and Analyst Event Highlighting Pipeline on April 8, 2026 - GlobeNewsWire
- 6 weeks ago - ProQR Announces Year End 2025 Operating and Financial Results - GlobeNewsWire
- 6 weeks ago - ProQR Therapeutics Transcript: The Citizens Life Sciences Conference 2026 - Transcripts
- 2 months ago - ProQR Announces Webcast of Presentation at the 2026 Citizens Life Sciences Conference - GlobeNewsWire
- 2 months ago - ProQR Announces Planned Changes to Board Composition - GlobeNewsWire